X4 Pharmaceuticals, Inc. (XFOR)

Last Closing Price: 2.98 (2026-11-18)

Normalized Income after Taxes (Quarterly)

Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.

X4 Pharmaceuticals, Inc. (XFOR) had Normalized Income after Taxes of $-20.20M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$2.88M
$-20.20M
$0.51M
$2.37M
$22.87M
$-19.99M
$-0.20M
$-20.20M
$-20.20M
$-20.20M
$-20.20M
$-20.20M
Normalized Income after Taxes
$-20.20M
$-19.99M
$-19.66M
126.52M
126.52M
$-0.16
$-0.16
Balance Sheet Financials
$198.13M
$0.06M
$33.68M
$231.82M
$14.98M
$77.01M
$77.95M
$92.93M
$138.88M
$108.71M
$138.88M
100.90M
Cash Flow Statement Financials
$-60.57M
$29.25M
$-0.04M
$217.85M
$186.48M
$-31.38M
$9.00M
--
--
Fundamental Metrics & Ratios
13.22
--
--
0.36
0.55
82.18%
-694.37%
-694.37%
--
-701.46%
-701.56%
$-60.57M
--
--
--
0.01
0.09
1.96
45.95
-14.54%
-18.58%
-8.71%
-9.36%
$1.38
$-0.48
$-0.48